
Research studies are enrolling now.
Those who qualify may receive*:
Plus, no cost to you.
No health insurance or referral needed.
For the safety of both staff and patients, we require that our research sites are COVID-19 SMART facilities. That means they use best practices to reduce virus exposure and are dedicated to ensuring they remain open and available for the research of investigational medications.
Major depression (MDD) is an extremely common condition worldwide. It causes symptoms such as loss of interest in activities and low energy. Feelings of hopelessness, worthlessness, and guilt can be overwhelming. MDD may lead to changes in in sleep patterns, too. Up to 75% of people with MDD have trouble falling and/or staying asleep at night, even with antidepressant use.
Right now, researchers are evaluating oral study medications that work with your current antidepressant medication to help treat unresolved symptoms of major depression. The study medications being evaluated have the potential to be an important option for the treatment of depression.
Take the next step to see if you qualify for local research studies for people with major depression. But don’t delay — space is limited!
Ready to get started?
Click Here.Tell us a little bit about yourself
Answer some questions about your health
We will connect you to available studies in your area
AcurianHealth helps connect people with research studies that offer treatment under development. Since 1998, AcurianHealth has referred 1 million study candidates to 800 studies in 70 countries.